Du M et al. have demonstrated that silencing IRF-1 alleviate atherosclerosis in mice by regulating lipid metabolism and foam cell formation, and suggest that IRF-1 activation is a risk factor for the occurrence and development of atherosclerosis [12]. Here, IRF1 is linked to atherosclerosis.